Singapore: The European Medicines Agency (EMA) has accepted the marketing authorization application for review of an aty...
New Delhi: Ranbaxy issued an advisory claiming that all their products in the Indian and global markets are safe and eff...
Singapore: Global biopharmaceutical company Amgen plans to acquire all the outstanding shares of Onyx Pharmaceuticals fo...
Singapore: The TRILOGY ACS study, a phase III trial comparing prasugrel plus aspirin to clopidogrel plus aspirin in pati...
Singapore:Â Takeda Pharmaceutical mutually terminated its worldwide agreement with Amylin Pharmaceuticals, which was o...
Singapore: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a posi...
Singapore: Astellas Pharma, Japan's pharmaceutical giant with net sales of $10.7 billion and net income of $881 million ...
Singapore:Â Sucampo Pharmaceuticals' subsidiary SPL has received a $15 million milestone payment from Abbott's subsidi...
Singapore:Â Eisai announched that Scotland's health technology assessment (HTA) body, the Scottish Medicines Consortiu...
Singapore:Â ZOLL Medical, a manufacturer of medical devices and related software solutions and a wholly owned US subsi...
Singapore:Â The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Neupro (rotigotine transdermal pat...
Singapore: AVEO Oncology and Astellas Pharma announced that the US Food and Drug Administration (FDA) has accep...
Singapore: Mundipharma has entered a license agreement with Japan-based Shionogi for the exclusive rights to develop, ma...
Singapore:Â Cytori Therapeutics announced that a 40-patient, multi-center investigator-sponsored and funded clinical s...
Singapore: Isogenica has appointed CTC Laboratory Systems (CTCLS) of Tokyo, Japan, to represent its business in Japan. C...
Singapore: ThermoGenesis, a leading supplier of enabling technologies for the processing, storage and administration of ...
Singapore: US based Sanford-Burnham Medical Research Institute and Japan's Daiichi Sankyo have formed a three year disco...
Singapore: Japan-based Takeda Global Research & Development Centre has received confirmation of the acceptance of su...
Singapore: Thailand hospital is planning to introduce Japanese cancer therapy technology using a heavy ion beam to treat...
Singapore: Swiss giant Novartis Pharma's Japanese arm has prompted the Japanese health ministry to launch an investigati...
Singapore: Genmab has entered into a research collaboration with Japan-based Kyowa Hakko Kirin to create bispecific anti...
Singapore: Japan Science and Technology Agency (JST) and the National Science and Technology Development Agency (NSTDA) ...
Singapore: Daiichi Sankyo has submitted an application for a partial label change in Japan to manufacture and market the...
Singapore: Mitsubishi Tanabe Pharma and Daiichi Sankyo will launch selective DPP-4 inhibitor Tenelia 20mg tablets (tenel...
7th in-Pharma Japan and 26th Interphex Japan, which was held from July 10-12, 2013, at Tokyo Big Sight, Japan...
